Physician

Reem Z. Renno, M.D.

According to 2025 Medicare claims, Reem Renno, M.D. (NPI: 1720056773) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. Renno uses personal NPI as billing NPI and primary practice location at 77070-6081.

Renno's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 624 traditional Medicare patients, billed 17,679 HCPCS/CPT codes, and received $3,642,056 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,225 prescription claims across 291 beneficiaries totaling $77,691 in drug costs, led by Lumigan (Bimatoprost). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $4,106,337 to $3,642,056. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.3M2015 Medicare payment: $4,106,337 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,241,792 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,302,200 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,785,894 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,437,506 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,225,247 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,732,373 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,673,201 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,842,298 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,642,056 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201544714,645$4,106,337
201648214,918$4,241,792
201750615,574$4,302,200
201851013,665$3,785,894
201948911,814$3,437,506
202041412,669$3,225,247
202144312,539$2,732,373
202248410,287$2,673,201
202355611,555$2,842,298
202462417,679$3,642,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$65K$130K2015 Drug cost: $71,283 (USD; Tot_Drug_Cst)2016 Drug cost: $85,526 (USD; Tot_Drug_Cst)2017 Drug cost: $92,586 (USD; Tot_Drug_Cst)2018 Drug cost: $103,113 (USD; Tot_Drug_Cst)2019 Drug cost: $129,998 (USD; Tot_Drug_Cst)2020 Drug cost: $125,075 (USD; Tot_Drug_Cst)2021 Drug cost: $102,250 (USD; Tot_Drug_Cst)2022 Drug cost: $100,874 (USD; Tot_Drug_Cst)2023 Drug cost: $100,013 (USD; Tot_Drug_Cst)2024 Drug cost: $77,691 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015129634$71,283
2016142702$85,526
2017183754$92,586
2018197815$103,113
2019207864$129,998
2020184752$125,075
2021192806$102,250
2022183772$100,874
2023230974$100,013
20242911,225$77,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2151,298$87
92012Established patient problem focused exam of visual system4521,403$60
92083Exam of visual field with extended testing288341$41
92250Photography of the retina234236$24
92133Imaging of optic nerve241277$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost331,815$14,958
Brimonidine TartrateBrimonidine Tartrate1215,961$8,773
Alphagan PBrimonidine Tartrate20971$8,425
Prednisolone AcetatePrednisolone Acetate1506,541$7,252
CombiganBrimonidine Tartrate/Timolol19644$5,148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Reem Z. Renno, M.D.?

Tedicare shows public-source Medicare data for Reem Z. Renno, M.D. (NPI 1720056773), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reem Z. Renno, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Reem Z. Renno, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Reem Z. Renno, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.